Cart
sales@molnova.com
Absinthiin
CAS No. 1362-42-1
Absinthiin( Absinthin | NSC 407315 | NSC-407315 )
Catalog No. M17973 CAS No. 1362-42-1
Absinthiin is a weak HIV-1 protease inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAbsinthiin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAbsinthiin is a weak HIV-1 protease inhibitor.
-
DescriptionAbsinthin is possible treatment candidate for Acute lung injury (ALI). ALI symptoms include severe lung inflammation. Absinthin causes an anti-inflammatory effect by enhancing activity of matrix metalloproteinase-8 (MMP-8), which inhibits grwoth of inflammatory cells.
-
In Vitro——
-
In VivoAnimal Model:LPS-induced acute lung injury in miceDosage:20, 40, 80mg/kg Administration:p.o.Result:Reduced inflammatory cell infiltration and improved lung architecture.Reduced MPO activity, infiltration of neutrophils, lung tissue wet-to-dry ratio.Reduced the secretion of proinflammatory cytokines and chemokines (TNF-α, IL-1β, IL-6, and MIP-1α).
-
SynonymsAbsinthin | NSC 407315 | NSC-407315
-
PathwayOthers
-
TargetOther Targets
-
RecptorHIV-1 protease
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number1362-42-1
-
Formula Weight496.64
-
Molecular FormulaC30H40O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1C2CCC(C3C4C5C=C(C6(C4C(=C3C2OC1=O)C)C5C(CCC7C6OC(=O)C7C)(C)O)C)(C)O
-
Chemical Name[no name]
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Geniposide
Geniposide is an iridoid glycoside with a variety of biological activities including neuroprotective,anti-diabetic,antiproliferative,and antioxidative activity.
-
ETHYL 2-AMINO-4-METH...
ETHYL 2-AMINO-4-METHYL-5-PHENYLTHIOPHENE-3-CARBOXYLATE targets the prostaglandin E2 receptor EP2 subtype (human).
-
Bimagrumab
Bimagrumab (BYM338) is a human monoclonal antibody that binds to the activin type II receptor. Bimagrumab can be used to study diabetes and obesity.
